Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ContraDyn

2006 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
3 INVESTORS
Description

Developer of targeted nanoscale drug delivery systems. The comp[any offers a nanoglobular drug delivery system for targeting tumors and chemotherapeutic agents for treating tumors without invasive surgery.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Primary Office
  • 615 Arapeen Drive
  • Suite 102
  • Salt Lake City, UT 84108
  • United States

+1 (801) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ContraDyn’s full profile, request a free trial.

ContraDyn Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC Completed Startup
1. Grant 01-Jul-2008 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ContraDyn Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cold Genesys Venture Capital-Backed Santa Ana, CA 000.00 00000000000 000.00
000000000 00000000 Failed Transaction (M&A) Canada 000000000000
To view this company’s complete list of competitors, request access »

ContraDyn Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government 000 0000 000000 0
Utah Centers of Excellence Government 000 0000 000000 0
UpStart Ventures Venture Capital Minority 000 0000 000000 0

ContraDyn Executive Team (1)

Name Title Board
Seat
Contact
Info
Dennis Farrar JD Chief Executive Officer & President